Multinational Survey-Based Chart Review Study in International Markets to Evaluate the Effectiveness, Safety, and Treatment Patterns of DUPIXENT® (Dupilumab) in Patients with Moderate-to-Severe Atopic Dermatitis
2022-11-27
عنوان الدراسة
Multinational Survey-Based Chart Review Study in International Markets to Evaluate the Effectiveness, Safety, and Treatment Patterns of DUPIXENT® (Dupilumab) in Patients with Moderate-to-Severe Atopic Dermatitis
داعم الدراسة
Sanofi-Aventis group
دواء الدراسة
DUPIXENT® (Dupilumab)
رقم بروتوكول الدراسة
DUT0012
حالة الدراسة
Completed
موقع الدراسة
Specialized Medical Center (Riyadh),Dr. Erfan & Bagedo General Hospital (Jeddah)
مرحلة الدراسة
4
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。